Pesquisa | Secretaria de Estado da Saúde

1.

HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy.

Sonneveld, Milan J; Chiu, Shao-Ming; Park, Jun Yong; Brakenhoff, Sylvia M; Kaewdech, Apichat; Seto, Wai-Kay; Tanaka, Yasuhito; Carey, Ivana; Papatheodoridi, Margarita; Colombatto, Piero; van Bömmel, Florian; Janssen, Harry L; Berg, Thomas; Zoulim, Fabien; Ahn, Sang Hoon; Dalekos, George N; Erler, Nicole S; Brunetto, Maurizia; Wedemeyer, Heiner; Cornberg, Markus; Yuen, Man-Fung; Agarwal, Kosh; Boonstra, Andre; Buti, Maria; Piratvisuth, Teerha; Papatheodoridis, George; Chen, Chien-Hung; Maasoumy, Benjamin.

Gastroenterology ; 166(1): 168-177.e8, 2024 Jan.

Artigo Inglês | MEDLINE | ID: mdl-37769952

2.

Inequities in primary liver cancer in Europe: The state of play.

Kondili, Loreta A; Lazarus, Jeffrey V; Jepsen, Peter; Murray, Frank; Schattenberg, Jörn M; Korenjak, Marko; Craxì, Lucia; Buti, Maria.

J Hepatol ; 80(4): 645-660, 2024 Apr.

Artigo Inglês | MEDLINE | ID: mdl-38237866

3.

Preventing liver disease with policy measures to tackle alcohol consumption and obesity: The HEPAHEALTH II study.

Retat, Lise; Webber, Laura; Jepsen, Peter; Martin, Alexander; Cortez-Pinto, Helena; Lazarus, Jeffrey V; Negro, Francesco; Mitchyn, Markiyan; Guzek, John; Card-Gowers, Joshua; Graff, Hannah; Nahon, Pierre; Sheron, Nick; Sagi, Shira Zelber; Buti, Maria.

J Hepatol ; 80(4): 543-552, 2024 Apr.

Artigo Inglês | MEDLINE | ID: mdl-38092157

4.

Hepatocellular carcinoma risk in sub-Saharan African and Afro-Surinamese individuals with chronic hepatitis B living in Europe.

Patmore, Lesley A; van Eekhout, Kirsi M A; Buti, Maria; Koc, Özgur M; Agarwal, Kosh; de Knegt, Rob J; Janssen, Harry L A; van der Valk, Marc; Lieveld, Faydra I; Hansen, Bettina E; Kramer, Matthijs; de Bruijne, Joep; Claassen, Mark A A; Smit, Colette; de Man, Rob A; Takkenberg, Bart; Carey, Ivana; Sonneveld, Milan J.

J Hepatol ; 80(2): 243-250, 2024 Feb.

Artigo Inglês | MEDLINE | ID: mdl-37898348

5.

JNJ-73763989 and bersacapavir treatment in nucleos(t)ide analog suppressed patients with chronic hepatitis B: REEF-2.

Agarwal, Kosh; Buti, Maria; van Bömmel, Florian; Lampertico, Pietro; Janczewska, Ewa; Bourliere, Marc; Vanwolleghem, Thomas; Lenz, Oliver; Verbinnen, Thierry; Kakuda, Thomas N; Mayer, Cristiana; Jezorwski, John; Muenz, Daniel; Beumont, Maria; Kalmeijer, Ronald; Biermer, Michael; Lonjon-Domanec, Isabelle.

J Hepatol ; 2024 Apr 05.

Artigo Inglês | MEDLINE | ID: mdl-38583491

6.

PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B.

Chun, Ho Soo; Papatheodoridis, George V; Lee, Minjong; Lee, Hye Ah; Kim, Yeong Hwa; Kim, Seo Hyun; Oh, Yun-Seo; Park, Su Jin; Kim, Jihye; Lee, Han Ah; Kim, Hwi Young; Kim, Tae Hun; Yoon, Eileen L; Jun, Dae Won; Ahn, Sang Hoon; Sypsa, Vana; Yurdaydin, Cihan; Lampertico, Pietro; Calleja, Jose Luis; Janssen, Harry LA; Dalekos, George N; Goulis, John; Berg, Thomas; Buti, Maria; Kim, Seung Up; Kim, Yoon Jun.

J Hepatol ; 80(1): 20-30, 2024 01.

Artigo Inglês | MEDLINE | ID: mdl-37734683

7.

The elimination of hepatitis D as a public health problem: Needs and challenges.

Vanwolleghem, Thomas; Armstrong, Paige A; Buti, Maria; FitzSimons, David; Valckx, Sara; Hendrickx, Greet; Van Damme, Pierre.

J Viral Hepat ; 31(1): 47-50, 2024 01.

Artigo Inglês | MEDLINE | ID: mdl-37789715

8.

Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference.

Ghany, Marc G; Buti, Maria; Lampertico, Pietro; Lee, Hannah M.

Hepatology ; 78(5): 1654-1673, 2023 11 01.

Artigo Inglês | MEDLINE | ID: mdl-37326326

9.

Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity.

Tedbury, Philip R; Manfredi, Candela; Degenhardt, Frauke; Conway, Joseph; Horwath, Michael C; McCracken, Courtney; Sorscher, Adam J; Moreau, Sandy; Wright, Christine; Edwards, Carolina; Brewer, Jo; Guarner, Jeannette; de Wit, Emmie; Williamson, Brandi N; Suthar, Mehul S; Ong, Yee T; Roback, John D; Alter, David N; Holter, Jan C; Karlsen, Tom H; Sacchi, Nicoletta; Romero-Gómez, Manuel; Invernizzi, Pietro; Fernández, Javier; Buti, Maria; Albillos, Agustin; Julià, Antonio; Valenti, Luca; Asselta, Rosanna; Banales, Jesus M; Bujanda, Luis; de Cid, Rafael; Franke, André; Sarafianos, Stefan G; Hong, Jeong S; Sorscher, Eric J; Ehrhardt, Annette.

FASEB J ; 37(11): e23220, 2023 11.

Artigo Inglês | MEDLINE | ID: mdl-37801035

10.

Assessing the rate of non-linkage to care and identifying barriers in individuals living with hepatitis B. Results of the LINK-B study.

Feliu-Prius, Anna; Barreira-Díaz, Ana; Rando, Ariadna; Vargas-Accarino, Elena; Palom, Adriana; Vico-Romero, Judit; Ruiz-Cobo, Juan C; Riveiro-Barciela, Mar; Rodriguez-Frias, Francisco; Esteban, Rafael; Buti, Maria.

Liver Int ; 44(3): 706-714, 2024 Mar.

Artigo Inglês | MEDLINE | ID: mdl-38111084

11.

Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational study.

Jang, Tyng-Yuan; Liang, Po-Cheng; Jun, Dae Won; Jung, Jang Han; Toyoda, Hidenori; Wang, Chih-Wen; Yuen, Man-Fung; Cheung, Ka Shing; Yasuda, Satoshi; Kim, Sung Eun; Yoon, Eileen L; An, Jihyun; Enomoto, Masaru; Kozuka, Ritsuzo; Chuma, Makoto; Nozaki, Akito; Ishikawa, Toru; Watanabe, Tsunamasa; Atsukawa, Masanori; Arai, Taeang; Hayama, Korenobu; Ishigami, Masatoshi; Cho, Yong Kyun; Ogawa, Eiichi; Kim, Hyoung Su; Shim, Jae-Jun; Uojima, Haruki; Jeong, Soung Won; Ahn, Sang Bong; Takaguchi, Koichi; Senoh, Tomonori; Buti, Maria; Vargas-Accarino I, Elena; Abe, Hiroshi; Takahashi, Hirokazu; Inoue, Kaori; Yeh, Ming-Lun; Dai, Chia-Yen; Huang, Jee-Fu; Huang, Chung-Feng; Chuang, Wan-Long; Nguyen, Mindie H; Yu, Ming-Lung.

J Gastroenterol Hepatol ; 2024 Mar 13.

Artigo Inglês | MEDLINE | ID: mdl-38480009

12.

Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection.

Janssen, Harry L A; Hou, Jinlin; Asselah, Tarik; Chan, Henry L Y; Zoulim, Fabien; Tanaka, Yasuhito; Janczewska, Ewa; Nahass, Ronald G; Bourgeois, Stefan; Buti, Maria; Lampertico, Pietro; Lenz, Oliver; Verbinnen, Thierry; Vandenbossche, Joris; Talloen, Willem; Kalmeijer, Ronald; Beumont, Maria; Biermer, Michael; Shukla, Umesh.

Gut ; 72(7): 1385-1398, 2023 07.

Artigo Inglês | MEDLINE | ID: mdl-36697207

13.

The pressing need for a global HEV vaccine.

Peron, Jean-Marie; Larrue, Hélène; Izopet, Jacques; Buti, Maria.

J Hepatol ; 79(3): 876-880, 2023 09.

Artigo Inglês | MEDLINE | ID: mdl-37003442

14.

Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference.

Ghany, Marc G; Buti, Maria; Lampertico, Pietro; Lee, Hannah M.

J Hepatol ; 79(5): 1254-1269, 2023 Nov.

Artigo Inglês | MEDLINE | ID: mdl-37377088

15.

Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries.

Razavi, Homie A; Buti, Maria; Terrault, Norah A; Zeuzem, Stefan; Yurdaydin, Cihan; Tanaka, Junko; Aghemo, Alessio; Akarca, Ulus S; Al Masri, Nasser M; Alalwan, Abduljaleel M; Aleman, Soo; Alghamdi, Abdullah S; Alghamdi, Saad; Al-Hamoudi, Waleed K; Aljumah, Abdulrahman A; Altraif, Ibrahim H; Asselah, Tarik; Ben-Ari, Ziv; Berg, Thomas; Biondi, Mia J; Blach, Sarah; Braga, Wornei S M; Brandão-Mello, Carlos E; Brunetto, Maurizia R; Cabezas, Joaquin; Cheinquer, Hugo; Chen, Pei-Jer; Cheon, Myeong-Eun; Chuang, Wan-Long; Coffin, Carla S; Coppola, Nicola; Craxi, Antonio; Crespo, Javier; De Ledinghen, Victor; Duberg, Ann-Sofi; Etzion, Ohad; Ferraz, Maria Lucia G; Ferreira, Paulo R A; Forns, Xavier; Foster, Graham R; Gaeta, Giovanni B; Gamkrelidze, Ivane; García-Samaniego, Javier; Gheorghe, Liliana S; Gholam, Pierre M; Gish, Robert G; Glenn, Jeffrey; Hercun, Julian; Hsu, Yao-Chun; Hu, Ching-Chih.

J Hepatol ; 79(2): 576-580, 2023 08.

Artigo Inglês | MEDLINE | ID: mdl-37030400

16.

Genomewide Association Study of Severe Covid-19 with Respiratory Failure.

Ellinghaus, David; Degenhardt, Frauke; Bujanda, Luis; Buti, Maria; Albillos, Agustín; Invernizzi, Pietro; Fernández, Javier; Prati, Daniele; Baselli, Guido; Asselta, Rosanna; Grimsrud, Marit M; Milani, Chiara; Aziz, Fátima; Kässens, Jan; May, Sandra; Wendorff, Mareike; Wienbrandt, Lars; Uellendahl-Werth, Florian; Zheng, Tenghao; Yi, Xiaoli; de Pablo, Raúl; Chercoles, Adolfo G; Palom, Adriana; Garcia-Fernandez, Alba-Estela; Rodriguez-Frias, Francisco; Zanella, Alberto; Bandera, Alessandra; Protti, Alessandro; Aghemo, Alessio; Lleo, Ana; Biondi, Andrea; Caballero-Garralda, Andrea; Gori, Andrea; Tanck, Anja; Carreras Nolla, Anna; Latiano, Anna; Fracanzani, Anna Ludovica; Peschuck, Anna; Julià, Antonio; Pesenti, Antonio; Voza, Antonio; Jiménez, David; Mateos, Beatriz; Nafria Jimenez, Beatriz; Quereda, Carmen; Paccapelo, Cinzia; Gassner, Christoph; Angelini, Claudio; Cea, Cristina; Solier, Aurora.

N Engl J Med ; 383(16): 1522-1534, 2020 10 15.

Artigo Inglês | MEDLINE | ID: mdl-32558485

17.

Retreatment With Immune Checkpoint Inhibitors After a Severe Immune-Related Hepatitis: Results From a Prospective Multicenter Study.

Riveiro-Barciela, Mar; Barreira-Díaz, Ana; Callejo-Pérez, Ana; Muñoz-Couselo, Eva; Díaz-Mejía, Nely; Díaz-González, Álvaro; Londoño, María-Carlota; Salcedo, Maria-Teresa; Buti, María.

Clin Gastroenterol Hepatol ; 21(3): 732-740, 2023 03.

Artigo Inglês | MEDLINE | ID: mdl-35487453

18.

Long-term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone Safety.

Chan, Henry L Y; Buti, Maria; Lim, Young-Suk; Agarwal, Kosh; Marcellin, Patrick; Brunetto, Maurizia; Chuang, Wan-Long; Janssen, Harry L A; Fung, Scott; Izumi, Namiki; Abdurakhmanov, Dzhamal; Jablkowski, Maciej; Celen, Mustafa K; Ma, Xiaoli; Caruntu, Florin; Flaherty, John F; Abramov, Frida; Wang, Hongyuan; Camus, Gregory; Osinusi, Anu; Pan, Calvin Q; Shalimar, Dr; Seto, Wai-Kay; Gane, Edward.

Am J Gastroenterol ; 2023 Aug 10.

Artigo Inglês | MEDLINE | ID: mdl-37561058

19.

Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™.

Younossi, Zobair M; Yu, Ming-Lung; Yilmaz, Yusuf; Alswat, Khalid Aida; Buti, Maria; Fernandez, Marlen Ivon Castellanos; Papatheodoridis, Georgios; Hamid, Saeed S; El-Kassas, Mohamed; Chan, Wah Kheong; Duseja, Ajay K; Gordon, Stuart C; Eguchi, Yuichiro; Isakov, Vasily A; Roberts, Stuart K; Fan, Jian-Gao; Singal, Ashwani K; Romero-Gómez, Manuel; Ahmed, Aijaz; Ong, Janus; Lam, Brian P; Younossi, Issah; Nader, Fatema; Racila, Andrei; Stepanova, Maria; Alqahtani, Saleh.

J Viral Hepat ; 30(4): 335-344, 2023 04.

Artigo Inglês | MEDLINE | ID: mdl-36601668

20.

Impact of hepatitis D reflex testing on the future disease burden: A modelling analysis.

Buti, Maria; Domínguez-Hernández, Raquel; Palom, Adriana; Esteban, Rafael; Casado, Miguel Ángel.

Liver Int ; 43(12): 2611-2614, 2023 12.

Artigo Inglês | MEDLINE | ID: mdl-37916574

Secretaria de Estado da Saúde - BVS

Rede de Informação e Conhecimento

Sua seleção (0)

Formato de exportação:

Exportar:

HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy.

Inequities in primary liver cancer in Europe: The state of play.

Preventing liver disease with policy measures to tackle alcohol consumption and obesity: The HEPAHEALTH II study.

Hepatocellular carcinoma risk in sub-Saharan African and Afro-Surinamese individuals with chronic hepatitis B living in Europe.

JNJ-73763989 and bersacapavir treatment in nucleos(t)ide analog suppressed patients with chronic hepatitis B: REEF-2.

PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B.

The elimination of hepatitis D as a public health problem: Needs and challenges.

Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference.

Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity.

Assessing the rate of non-linkage to care and identifying barriers in individuals living with hepatitis B. Results of the LINK-B study.

Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational study.

Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection.

The pressing need for a global HEV vaccine.

Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference.

Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries.

Genomewide Association Study of Severe Covid-19 with Respiratory Failure.

Retreatment With Immune Checkpoint Inhibitors After a Severe Immune-Related Hepatitis: Results From a Prospective Multicenter Study.

Long-term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone Safety.

Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™.

Impact of hepatitis D reflex testing on the future disease burden: A modelling analysis.